enterothera.com - Total Nilai Bisnis ENTO

The efficiency of gastrointestinal drug deliveries for Entero Therapeutics, Inc. (ENTO) relies on a streamlined pharmacy network and the control of warehousing costs. The current Enterprise Value on the GURU.Markets platform is 75.34, while price action is accompanied by rising laboratory expenses due to a lack of revenue during the testing phase. The company's strategy is based on capturing market niches by introducing innovative formulas for the treatment of orphan pathologies.

Nilai Total Perusahaan Entero Therapeutics Inc. (ENTO): kanggo periode 23.11.2025 - 01.12.2025

Entero Therapeutics (ENTO) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Kurs saham Entero Therapeutics Inc.|ENTO - Target konsensus

- rincian nilai pasar emiten:

Nilai pasar Entero Therapeutics|ENTO - Nilai Total Perusahaan

- statistik nilai buku emiten:

Nilai Aset Bersih saben Saham Entero Therapeutics|ENTO - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih enterothera.com|ENTO - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Kabeh Utang marang Dana Pribadi Entero Therapeutics, Inc.|ENTO - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Entero Therapeutics Inc.|ENTO - Utang perusahaan|Rasio utang marang aset resik Entero Therapeutics|ENTO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Entero Therapeutics|Rasio cepet enterothera.com

- rincian bathi lan kelipatan pasar:

ENTO - Penghasilan resik

Analisis kabeh metrik perusahaan:Entero Therapeutics, Inc.

Enterprise Value (EV) represents the total buyout price of a company, combining market capitalization and net debt. By tracking changes in EV, an investor assesses the real value of Entero Therapeutics, Inc. (ENTO) assets, which will depend significantly on the future effectiveness of commercializing innovative drugs for the treatment of celiac disease and inflammatory bowel diseases.

Pesaing Entero Therapeutics, Inc. (ENTO)